Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOW FROM OPERATING ACTIVITIES
Net income	$ 3,198	$ 3,498
Adjustments to reconcile net income to net cash provided by operating activities:
Discontinued operations, net	(182)	0
Depreciation, depletion and amortization of assets	5,394	5,142
Deferred income tax provision (benefit)	(182)	148
Asset impairments and other charges	21	209
(Gains) losses on sales of assets, net	52	(197)
Noncash charges to income and other	339	343
Changes in operating assets and liabilities:
(Increase) decrease in receivables	(532)	609
Increase in inventories	(226)	(44)
(Increase) decrease in other current assets	219	(367)
Decrease in accounts payable and accrued liabilities	(430)	(583)
Increase in current domestic and foreign income taxes	512	311
Operating cash flow from continuing operations	8,183	9,069
Operating cash flow from discontinued operations, net of taxes	(100)	0
Net cash provided by operating activities	8,083	9,069
CASH FLOW FROM INVESTING ACTIVITIES
Capital expenditures	(5,237)	(4,726)
Change in capital accrual	(39)	(48)
Purchases of assets, businesses and equity investments, net	(9,037)	(220)
Proceeds from sales of assets and equity investments, net	1,662	405
Equity investments and other, net	(149)	(422)
Net cash used by investing activities	(12,800)	(5,011)
CASH FLOW FROM FINANCING ACTIVITIES
Draws on receivables securitization facility	0	900
Payment of receivables securitization facility	0	(900)
Proceeds from long-term debt, net	9,612	0
Payments of long-term debt, net	(4,007)	(22)
Proceeds from issuance of common stock	571	92
Redemption of preferred stock	0	(1,661)
Purchases of treasury stock	(9)	(1,611)
Cash dividends paid on common and preferred stock	(1,069)	(1,035)
Contributions from noncontrolling interest	146	0
Payment for taxes related to stock-based award settlement	(103)	(99)
Other financing, net	(95)	(99)
Net cash provided (used) by financing activities	5,046	(4,435)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	329	(377)
Cash, cash equivalents, restricted cash and restricted cash equivalents — beginning of period	1,464	1,026
Cash, cash equivalents, restricted cash and restricted cash equivalents — end of period	$ 1,793	$ 649